Navigation Links
Shire to Present at the Goldman Sachs 34th Annual Global Healthcare Conference
Date:6/11/2013

LEXINGTON, Massachusetts, June 11, 2013 /PRNewswire/ --


Shire's Chief Financial Officer, Graham Hetherington will present at the Goldman Sachs 34th Annual Global Healthcare Conference on Wednesday, June 12th at 9:20 AM PT /17:20 BST. Investors may access a live audio webcast of the presentation at http://www.shire.com/shireplc/en/investors.

NOTES TO EDITORS

Shire enables people with life-altering conditions to lead better lives.

Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.

We provide treatments in Neuroscience, Rare Diseases, Gastrointestinal, Internal Medicine and Regenerative Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas.

http://www.shire.com

For further information please contact:

Investor Relations:

Souheil Salah, ssalah@shire.com, +44-1256-894160

Erin K. Kelly, erikelly@shire.com, +1-781-482-9541


'/>"/>
SOURCE Shire plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Shire Launches Report that Quantifies the Health, Psycho-social and Economic Impact of Rare Diseases
2. Shire to Acquire SARcode Bioscience, Expands Presence in Ophthalmology
3. Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa
4. Shire Reaches Agreement in Principle With U.S. Government
5. Shire and Boston Childrens Hospital Enter Into Broad Research Collaboration
6. Dr. Jeff Jonas Appointed President of Shire Regenerative Medicine Business and Joins Shire Leadership Team
7. Shire Changes its NASDAQ Ticker Symbol to SHPG
8. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
9. Shire Facebook Page Increases Awareness of Hereditary Angioedema (HAE) in Support of First HAE Awareness Day May 16th
10. Shire plc: First Quarter 2012 Results Date Notification - April 26, 2012
11. Heptares Grants Shire an Exclusive Worldwide Licence to Develop and Commercialise Novel Drug Candidate for CNS Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... (PRWEB) , ... October 10, ... ... development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed ... targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with ...
(Date:10/10/2017)... SANTA BARBARA, CALIFORNIA (PRWEB) , ... October 10, ... ... risk management, technological innovation and business process optimization firm for the life sciences ... the BoxWorks conference in San Francisco. , The presentation, “Automating GxP ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree Wellness Center ... the needs of consumers who are incorporating medical marijuana into their wellness and ... , As operators of two successful Valley dispensaries, The Giving Tree’s two founders, ...
(Date:10/6/2017)... ... 06, 2017 , ... The HealthTech Venture Network (HTVN) is ... fourth annual Conference where founders, investors, innovative practitioners and collaborators are invited to ... showcasing early stage digital health and med tech companies. , This day-long event ...
Breaking Biology Technology:
(Date:4/19/2017)... The global military biometrics market ... by the presence of several large global players. The ... major players - 3M Cogent, NEC Corporation, M2SYS Technology, ... 61% of the global military biometric market in 2016. ... military biometrics market boast global presence, which has catapulted ...
(Date:4/13/2017)... PUNE, India , April 13, 2017 According ... Identity Proofing, Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication ... by MarketsandMarkets™, the IAM Market is expected to grow from USD 14.30 ... Annual Growth Rate (CAGR) of 17.3%. ... ...
(Date:4/11/2017)... April 11, 2017 NXT-ID, Inc. (NASDAQ: ... company, announces the appointment of independent Directors Mr. Robin ... its Board of Directors, furthering the company,s corporate governance and ... Gino Pereira ... look forward to their guidance and benefiting from their considerable ...
Breaking Biology News(10 mins):